Giuseppe Damante

Giuseppe Damante

UNVERIFIED PROFILE

Are you Giuseppe Damante?   Register this Author

Register author
Giuseppe Damante

Giuseppe Damante

Publications by authors named "Giuseppe Damante"

Are you Giuseppe Damante?   Register this Author

100Publications

1938Reads

36Profile Views

Quantitative PCR evaluation of deletions/duplications identified by array CGH.

Mol Cell Probes 2019 Aug 11;46:101421. Epub 2019 Jul 11.

Department of Medicine, University of Udine, Udine, Italy; Institute of Medical Genetics, Academic Hospital "Azienda Sanitaria Universitaria Integrata di Udine", Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mcp.2019.101421DOI Listing
August 2019

Molecular defects in thyroid dysgenesis.

Clin Genet 2019 Aug 21. Epub 2019 Aug 21.

Department of Medicine, University of Udine, 33100 Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cge.13627DOI Listing
August 2019

Biological and molecular effects of bromodomain and extra-terminal (BET) inhibitors JQ1, IBET-151, and IBET-762 in OSCC cells.

J Oral Pathol Med 2019 Mar 24;48(3):214-221. Epub 2019 Jan 24.

Department of Human Genetics, School of Dental Medicine, University of Belgrade, Belgrade, Serbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jop.12824DOI Listing
March 2019

Mesomelia-synostoses syndrome: Description of a patient presenting a monoallelic expression of SULF1 without alterations in the SLCOA1 gene.

Clin Genet 2019 Feb 18;95(2):336-338. Epub 2018 Nov 18.

Regional Coordinator Centre for Rare Diseases, Department of Laboratory Medicine, Academic Hospital "Santa Maria della Misericordia" Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/cge.13464
Publisher Site
http://dx.doi.org/10.1111/cge.13464DOI Listing
February 2019

Reading Cancer: Chromatin Readers as Druggable Targets for Cancer Treatment.

Cancers (Basel) 2019 Jan 9;11(1). Epub 2019 Jan 9.

Department of Medical Area, University of Udine, 33100 Udine, Italy.

View Article

Download full-text PDF

Source
http://www.mdpi.com/2072-6694/11/1/61
Publisher Site
http://dx.doi.org/10.3390/cancers11010061DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356452PMC
January 2019

Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches.

Minerva Endocrinol 2018 Sep 7;43(3):285-293. Epub 2017 Sep 7.

Department of Medical Area, University of Udine, Udine, Italy -

View Article

Download full-text PDF

Source
http://dx.doi.org/10.23736/S0391-1977.17.02735-3DOI Listing
September 2018

Targeting post-translational histone modifications for the treatment of non-medullary thyroid cancer.

Mol Cell Endocrinol 2018 07 2;469:38-47. Epub 2017 Jun 2.

Department of Health Sciences, "Magna Graecia" University of Catanzaro, 88100 Catanzaro, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mce.2017.05.036DOI Listing
July 2018

Effects of nutraceuticals on anaplastic thyroid cancer cells.

J Cancer Res Clin Oncol 2018 Feb 2;144(2):285-294. Epub 2017 Dec 2.

Department of Medical Area, University of Udine, 33100, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-017-2555-7DOI Listing
February 2018

BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells.

Oncol Rep 2018 Feb 12;39(2):582-588. Epub 2017 Dec 12.

Department of Medical Area, University of Udine, I-33100 Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2017.6152DOI Listing
February 2018

Expression of YAP1 in aggressive thyroid cancer.

Endocrine 2018 01 24;59(1):209-212. Epub 2017 Jan 24.

Department of Health Sciences, "Magna Graecia" University of Catanzaro, Viale Europa, Germaneto, Catanzaro, 88100, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12020-017-1240-6DOI Listing
January 2018

A polymorphic GGC repeat in the NPAS2 gene and its association with melanoma.

Exp Biol Med (Maywood) 2017 09 11;242(15):1553-1558. Epub 2017 Aug 11.

2 Department of Biotechnology, Centre for High-Throughput Technologies, University of Rijeka, Rijeka 51000, Croatia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1535370217724093DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648290PMC
September 2017

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.

Authors:
Julie Lecarpentier Valentina Silvestri Karoline B Kuchenbaecker Daniel Barrowdale Joe Dennis Lesley McGuffog Penny Soucy Goska Leslie Piera Rizzolo Anna Sara Navazio Virginia Valentini Veronica Zelli Andrew Lee Ali Amin Al Olama Jonathan P Tyrer Melissa Southey Esther M John Thomas A Conner David E Goldgar Saundra S Buys Ramunas Janavicius Linda Steele Yuan Chun Ding Susan L Neuhausen Thomas V O Hansen Ana Osorio Jeffrey N Weitzel Angela Toss Veronica Medici Laura Cortesi Ines Zanna Domenico Palli Paolo Radice Siranoush Manoukian Bernard Peissel Jacopo Azzollini Alessandra Viel Giulia Cini Giuseppe Damante Stefania Tommasi Paolo Peterlongo Florentia Fostira Ute Hamann D Gareth Evans Alex Henderson Carole Brewer Diana Eccles Jackie Cook Kai-Ren Ong Lisa Walker Lucy E Side Mary E Porteous Rosemarie Davidson Shirley Hodgson Debra Frost Julian Adlard Louise Izatt Ros Eeles Steve Ellis Marc Tischkowitz Andrew K Godwin Alfons Meindl Andrea Gehrig Bernd Dworniczak Christian Sutter Christoph Engel Dieter Niederacher Doris Steinemann Eric Hahnen Jan Hauke Kerstin Rhiem Karin Kast Norbert Arnold Nina Ditsch Shan Wang-Gohrke Barbara Wappenschmidt Dorothea Wand Christine Lasset Dominique Stoppa-Lyonnet Muriel Belotti Francesca Damiola Laure Barjhoux Sylvie Mazoyer Mattias Van Heetvelde Bruce Poppe Kim De Leeneer Kathleen B M Claes Miguel de la Hoya Vanesa Garcia-Barberan Trinidad Caldes Pedro Perez Segura Johanna I Kiiski Kristiina Aittomäki Sofia Khan Heli Nevanlinna Christi J van Asperen Tibor Vaszko Miklos Kasler Edith Olah Judith Balmaña Sara Gutiérrez-Enríquez Orland Diez Alex Teulé Angel Izquierdo Esther Darder Joan Brunet Jesús Del Valle Lidia Feliubadalo Miquel Angel Pujana Conxi Lazaro Adalgeir Arason Bjarni A Agnarsson Oskar Th Johannsson Rosa B Barkardottir Elisa Alducci Silvia Tognazzo Marco Montagna Manuel R Teixeira Pedro Pinto Amanda B Spurdle Helene Holland Jong Won Lee Min Hyuk Lee Jihyoun Lee Sung-Won Kim Eunyoung Kang Zisun Kim Priyanka Sharma Timothy R Rebbeck Joseph Vijai Mark Robson Anne Lincoln Jacob Musinsky Pragna Gaddam Yen Y Tan Andreas Berger Christian F Singer Jennifer T Loud Mark H Greene Anna Marie Mulligan Gord Glendon Irene L Andrulis Amanda Ewart Toland Leigha Senter Anders Bojesen Henriette Roed Nielsen Anne-Bine Skytte Lone Sunde Uffe Birk Jensen Inge Sokilde Pedersen Lotte Krogh Torben A Kruse Maria A Caligo Sook-Yee Yoon Soo-Hwang Teo Anna von Wachenfeldt Dezheng Huo Sarah M Nielsen Olufunmilayo I Olopade Katherine L Nathanson Susan M Domchek Christa Lorenchick Rachel C Jankowitz Ian Campbell Paul James Gillian Mitchell Nick Orr Sue Kyung Park Mads Thomassen Kenneth Offit Fergus J Couch Jacques Simard Douglas F Easton Georgia Chenevix-Trench Rita K Schmutzler Antonis C Antoniou Laura Ottini

J Clin Oncol 2017 Jul 27;35(20):2240-2250. Epub 2017 Apr 27.

Julie Lecarpentier, Karoline B. Kuchenbaecker, Daniel Barrowdale, Joe Dennis, Lesley McGuffog, Goska Leslie, Andrew Lee, Ali Amin Al Olama, Jonathan P. Tyrer, Debra Frost, Steve Ellis, Douglas F. Easton, and Antonis C. Antoniou, University of Cambridge; Karoline B. Kuchenbaecker, The Wellcome Trust Sanger Institute, Hinxton; Marc Tischkowitz, Addenbrooke's Treatment Centre, Addenbrooke's Hospital, Cambridge; D. Gareth Evans, Manchester University, Central Manchester University Hospitals NHS Foundation Trust, Manchester; Alex Henderson, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne; Carole Brewer, Royal Devon and Exeter Hospital, Exeter; Diana Eccles, Southampton University Hospitals NHS Trust, Southampton; Jackie Cook, Sheffield Children's Hospital, Sheffield; Kai-ren Ong, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham; Lisa Walker, Churchill Hospital, Oxford; Lucy E. Side, Great Ormond Street Hospital for Children NHS Trust; Shirley Hodgson, St George's, University of London; Louise Izatt, Guy's and St Thomas' NHS Foundation Trust; Ros Eeles, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust; Nick Orr, The Institute of Cancer Research, London; Mary E. Porteous, Western General Hospital, Edinburgh; Rosemarie Davidson, South Glasgow University Hospitals, Glasgow; Julian Adlard, Chapel Allerton Hospital, Leeds, United Kingdom; Valentina Silvestri, Piera Rizzolo, Anna Sara Navazio, Virginia Valentini, Veronica Zelli, and Laura Ottini, Sapienza University of Rome, Rome; Angela Toss, Veronica Medici, and Laura Cortesi, University of Modena and Reggio Emilia, Modena; Ines Zanna and Domenico Palli, Cancer Research and Prevention Institute, Florence; Paolo Radice, Siranoush Manoukian, Bernard Peissel, and Jacopo Azzollini, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori (INT); Paolo Peterlongo, Italian Foundation for Cancer Research Institute of Molecular Oncology (IFOM), Milan; Alessandra Viel and Giulia Cini, CRO Aviano, National Cancer Institute, Aviano; Giuseppe Damante, University of Udine, Udine; Stefania Tommasi, Istituto Nazionale Tumori "Giovanni Paolo II", Bari; Elisa Alducci, Silvia Tognazzo, and Marco Montagna, Veneto Institute of Oncology IOV - IRCCS, Padua; Maria A. Caligo, University and University Hospital of Pisa, Pisa, Italy; Penny Soucy and Jacques Simard, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec; Anna Marie Mulligan and Irene L. Andrulis, University of Toronto; Gord Glendon and Irene L. Andrulis, Mount Sinai Hospital, Toronto, Ontario, Canada; Melissa Southey, Ian Campbell, Paul James, and Gillian Mitchell, University of Melbourne, Parkville, Victoria; Amanda B. Spurdle, Helene Holland, and Georgia Chenevix-Trench, QIMR Berghofer Medical Research Institute, Brisbane, Queensland; Ian Campbell, Paul James, and Gillian Mitchell, Peter MacCallum Cancer Centre, East Melbourne, New South Wales, Australia; Esther M. John, Cancer Prevention Institute of California, Fremont; Linda Steele, Yuan Chun Ding, Susan L. Neuhausen, and Jeffrey N. Weitzel, City of Hope, Duarte, CA; Thomas A. Conner and Saundra S. Buys, Huntsman Cancer Institute; David E. Goldgar, University of Utah School of Medicine, Salt Lake City, UT; Andrew K. Godwin, University of Kansas Medical Center, Kansas City; Priyanka Sharma, University of Kansas Medical Center, Westwood, KS; Timothy R. Rebbeck, Harvard TH Chan School of Public Health and Dana Farber Cancer Institute, Boston, MA; Joseph Vijai, Mark Robson, Anne Lincoln, Jacob Musinsky, Pragna Gaddam, and Kenneth Offit, Memorial Sloan Kettering Cancer Center, New York, NY; Jennifer T. Loud and Mark H. Greene, National Cancer Institute, Bethesda, MD; Amanda Ewart Toland and Leigha Senter, The Ohio State University, Columbus, OH; Dezheng Huo, Sarah M. Nielsen, and Olufunmilayo I. Olopade, University of Chicago Medical Center, Chicago, IL; Katherine L. Nathanson and Susan M. Domchek, University of Pennsylvania, Philadelphia; Christa Lorenchick and Rachel C. Jankowitz, University of Pittsburgh Medical Center, Pittsburgh, PA; Fergus J. Couch, Mayo Clinic, Rochester, MN; Ramunas Janavicius, State Research Institute Innovative Medicine Center, Vilnius, Lithuania; Thomas V.O. Hansen, Rigshospitalet, Copenhagen University Hospital, Copenhagen; Anders Bojesen and Henriette Roed Nielsen, Vejle Hospital, Vejle; Anne-Bine Skytte, Lone Sunde, and Uffe Birk Jensen, Aarhus University Hospital, Aarhus; Inge Sokilde Pedersen, Aalborg University Hospital, Aalborg; Lotte Krogh, Torben A. Kruse, and Mads Thomassen, Odense University Hospital, Odense, Denmark; Ana Osorio, National Cancer Research Centre and Spanish Network on Rare Diseases; Miguel de la Hoya, Vanesa Garcia-Barberan, Trinidad Caldes, and Pedro Perez Segura, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid; Judith Balmaña, University Hospital, Vall d'Hebron; Sara Gutiérrez-Enríquez and Orland Diez, Vall d'Hebron Institute of Oncology; Orland Diez, University Hospital Vall d'Hebron; Alex Teulé, Jesús Del Valle, Lidia Feliubadalo, Miquel Angel Pujana, and Conxi Lazaro, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, Barcelona; Angel Izquierdo, Esther Darder, and Joan Brunet, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain; Florentia Fostira, National Centre for Scientific Research "Demokritos," Athens, Greece; Ute Hamann, German Cancer Research Center (DKFZ); Christian Sutter, University Hospital Heidelberg, Heidelberg; Alfons Meindl, Klinikumrechts der Isar, Technical University Munich; Nina Ditsch, Ludwig-Maximilian University, Munich; Andrea Gehrig, University Würzburg, Würzburg; Bernd Dworniczak, University of Münster, Münster; Christoph Engel, University of Leipzig; Dorothea Wand, University Hospital, Leipzig; Dieter Niederacher, University Hospital Düsseldorf, Heinrich-Heine University, Düsseldorf; Doris Steinemann, Hannover Medical School, Hannover; Eric Hahnen, Jan Hauke, Kerstin Rhiem, Barbara Wappenschmidt, and Rita K. Schmutzler, University Hospital Cologne, Cologne; Karin Kast, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden; Norbert Arnold, University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel, Kiel; Shan Wang-Gohrke, University Hospital Ulm, Ulm, Germany; Christine Lasset, Francesca Damiola, and Laure Barjhoux, Centre Léon Bérard; Sylvie Mazoyer, University of Lyon, Lyon; Dominique Stoppa-Lyonnet and Muriel Belotti, Institut Curie, Paris, France; Mattias Van Heetvelde, Bruce Poppe, Kim De Leeneer, and Kathleen B.M. Claes, Ghent University, Gent, Belgium; Johanna I. Kiiski, Sofia Khan, and Heli Nevanlinna, University of Helsinki; Johanna I. Kiiski, Kristiina Aittomäki, Sofia Khan, and Heli Nevanlinna, Helsinki University Hospital, Helsinki, Finland; Christi J. van Asperen, Leiden University Medical Center, Leiden, the Netherlands; Tibor Vaszko, Miklos Kasler, and Edith Olah, National Institute of Oncology, Budapest, Hungary; Adalgeir Arason, Bjarni A. Agnarsson, Oskar Th. Johannsson, and Rosa B. Barkardottir, Landspitali University Hospital and Biomedical Centre, University of Iceland, Reykjavik, Iceland; Manuel R. Teixeira and Pedro Pinto, Portuguese Oncology Institute; Manuel R. Teixeira, Porto University, Porto, Portugal; Jong Won Lee, Ulsan College of Medicine and Asan Medical Center; Min Hyuk Lee and Jihyoun Lee, Soonchunhyang University and Hospital; Sung-Won Kim and Eunyoung Kang, Daerim St Mary's Hospital; Sue Kyung Park, Seoul National University College of Medicine, Seoul; Zisun Kim, Soonchunhyang University Bucheon Hospital, Bucheon, Korea; Yen Y. Tan, Andreas Berger, and Christian F. Singer, Medical University of Vienna, Vienna, Austria; Sook-Yee Yoon and Soo-Hwang Teo, Sime Darby Medical Centre, Subang Jaya, Malaysia; and Anna von Wachenfeldt, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.4935DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501359PMC
July 2017

A CGH array procedure to detect PAX6 gene structural defects.

Mol Cell Probes 2017 04 2;32:65-68. Epub 2016 Dec 2.

Istituto di Genetica Medica, Azienda Ospedaliero-Universitaria di Udine, Italy; Dipartimento di Scienze Mediche e Biologiche, Università di Udine, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mcp.2016.12.001DOI Listing
April 2017

Familial 5q12.3 Microdeletion: Evidence for a Locus Associated with Epilepsy.

Mol Syndromol 2017 Mar 17;8(2):98-102. Epub 2017 Jan 17.

Istituto di Genetica Medica, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/454725
Publisher Site
http://dx.doi.org/10.1159/000454725DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465700PMC
March 2017

Microdeletion 15q26.2qter and Microduplication 18q23 in a Patient with Prader-Willi-Like Syndrome: Clinical Findings.

Cytogenet Genome Res 2016 5;148(1):14-8. Epub 2016 May 5.

Dipartimento di Medicina di Laboratorio, Azienda Ospedaliero-Universitaria S. Maria della Misericordia, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000445923DOI Listing
January 2017

Molecular profiles of cancer stem-like cell populations in aggressive thyroid cancers.

Endocrine 2016 Jul 14;53(1):145-56. Epub 2015 Sep 14.

Dipartimento di Medicina Interna e Specialità Mediche, Università di Roma "Sapienza", Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12020-015-0739-yDOI Listing
July 2016

Immunoglobulin K light chain deficiency: A rare, but probably underestimated, humoral immune defect.

Eur J Med Genet 2016 Apr 4;59(4):219-22. Epub 2016 Feb 4.

Institute of Medical Genetics, Department of Laboratory Medicine, University of Udine, Italy; Department of Medical and Biological Sciences, University of Udine, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S17697212163001
Publisher Site
http://dx.doi.org/10.1016/j.ejmg.2016.02.003DOI Listing
April 2016

Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells.

Oncol Rep 2016 Apr 5;35(4):2413-8. Epub 2016 Feb 5.

Department of Medical and Biological Sciences, University of Udine, 33100 Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2016.4614DOI Listing
April 2016

Somatic amplifications and deletions in genome of papillary thyroid carcinomas.

Endocrine 2015 Nov 12;50(2):453-64. Epub 2015 Apr 12.

Azienda Ospedaliero-Universitaria S. Maria della Misericordia, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12020-015-0592-zDOI Listing
November 2015

A 16q deletion involving FOXF1 enhancer is associated to pulmonary capillary hemangiomatosis.

BMC Med Genet 2015 Oct 13;16:94. Epub 2015 Oct 13.

Dipartimento di Medicina di Laboratorio, Azienda Ospedaliero-Universitaria S. Maria della Misericordia, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12881-015-0241-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605103PMC
October 2015

Thrombophilic mutations as risk factor for retinal vein occlusion: a case-control study.

Clin Appl Thromb Hemost 2015 May 25;21(4):373-7. Epub 2014 Feb 25.

Center for Hemorrhagic and Thrombotic Diseases, University Hospital of Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1076029614522544DOI Listing
May 2015

Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells.

Oncol Rep 2015 May 23;33(5):2199-206. Epub 2015 Mar 23.

Department of Medical and Biological Sciences, University of Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2015.3873DOI Listing
May 2015

Blood-brain barrier dysfunction in disorders of the developing brain.

Front Neurosci 2015 17;9:40. Epub 2015 Feb 17.

INSERM U1141, Robert Debre's Hospital Paris, France ; Université Paris Diderot, Sorbonne Paris Cité, UMRS 1141-PROTECT Paris, France ; PremUP Paris, France ; Department of Division of Imaging Sciences and Biomedical Engineering, Centre for the Developing Brain, St. Thomas' Hospital London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fnins.2015.00040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330788PMC
March 2015

SOX2, OTX2 and PAX6 analysis in subjects with anophthalmia and microphthalmia.

Eur J Med Genet 2015 Feb 23;58(2):66-70. Epub 2014 Dec 23.

Department of Laboratory Medicine, Medical Genetics, Niguarda Ca' Granda Hospital, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmg.2014.12.005DOI Listing
February 2015

Synergy between HDAC and PARP Inhibitors on Proliferation of a Human Anaplastic Thyroid Cancer-Derived Cell Line.

Int J Endocrinol 2015 29;2015:978371. Epub 2015 Jan 29.

Department of Medical and Biological Sciences, University of Udine, Piazzale Kolbe 4, 33100 Udine, Italy ; Institute of Medical Genetics, University Hospital "S. Maria della Misericordia", 33100 Udine, Italy.

View Article

Download full-text PDF

Source
http://downloads.hindawi.com/journals/ije/2015/978371.pdf
Web Search
http://www.hindawi.com/journals/ije/2015/978371/
Publisher Site
http://dx.doi.org/10.1155/2015/978371DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326215PMC
February 2015

Histone post-translational modifications induced by histone deacetylase inhibition in transcriptional control units of NIS gene.

Mol Biol Rep 2014 Aug 21;41(8):5257-65. Epub 2014 May 21.

Department of Medical and Biological Sciences, University of Udine, Piazzale Kolbe 4, 33100, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11033-014-3397-xDOI Listing
August 2014

Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics.

J Mol Endocrinol 2014 Apr 30;52(2):121-31. Epub 2014 Jan 30.

Department of Health Sciences, University of Catanzaro 'Magna Graecia', Campus 'S. Venuta', Viale Europa, Germaneto, 88100 Catanzaro, Italy Departments of Internal Medicine and Medical Specialties Surgical Sciences, University of Roma 'Sapienza', 00161 Roma, Italy Department of Medical and Biological Sciences, University of Udine, 33100 Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/JME-13-0160DOI Listing
April 2014

Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer.

BMC Cancer 2014 Apr 30;14:303. Epub 2014 Apr 30.

Department of Urology, University of Modena and Reggio Emilia, Via Largo del Pozzo, 71, Modena 41100, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-14-303DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019362PMC
April 2014

BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients.

Am J Hematol 2013 Oct 23;88(10):848-52. Epub 2013 Jul 23.

Division of Hematology and Bone Marrow Transplantation, Azienda Ospedaliero-Universitaria Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23516DOI Listing
October 2013

One-step nucleic acid amplification (OSNA) for intraoperative evaluation of sentinel lymph node status in breast cancer: a comparative study between CK19 protein expression and CK19 mRNA level in primary tumors and lymph node metastasis.

Virchows Arch 2013 Jul 19;463(1):7-15. Epub 2013 Jun 19.

Department of Medical and Biological Sciences, Institution of Anatomic Pathology, Azienda Ospedaliero Universitaria S. Maria della Misericordia, Piazzale S. Maria della Misericordia, Udine 33100, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-013-1440-2DOI Listing
July 2013

Targeting histone deacetylase in thyroid cancer.

Expert Opin Ther Targets 2013 Feb 13;17(2):179-93. Epub 2012 Dec 13.

University Magna Graecia of Catanzaro, Department of Health Sciences, Campus S. Venuta, 88100 Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728222.2013.740013DOI Listing
February 2013

The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell lines.

Mol Cell Endocrinol 2013 Jan 5;365(1):1-10. Epub 2012 Sep 5.

Dipartimento di Scienze Mediche e Biologiche, Università di Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mce.2012.08.019DOI Listing
January 2013

CASR gene activating mutations in two families with autosomal dominant hypocalcemia.

Mol Genet Metab 2012 Nov 26;107(3):548-52. Epub 2012 Jun 26.

Medical Genetics, IRCCS Casa Sollievo della Sofferenza Hospital, viale Padre Pio, 71013 San Giovanni Rotondo, FG, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymgme.2012.06.012DOI Listing
November 2012

Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers.

Biochem Biophys Res Commun 2012 Jul 16;424(1):34-9. Epub 2012 Jun 16.

Department of Medical and Biological Sciences, University of Udine, 33100 Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2012.06.039DOI Listing
July 2012

Expression of Dicer and Drosha in triple-negative breast cancer.

J Clin Pathol 2012 Apr 18;65(4):320-6. Epub 2012 Jan 18.

Dipartimento di Scienze Mediche e Biologiche, Università di Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://jcp.bmj.com/content/early/2012/01/17/jclinpath-2011-2
Web Search
http://jcp.bmj.com/cgi/doi/10.1136/jclinpath-2011-200496
Publisher Site
http://dx.doi.org/10.1136/jclinpath-2011-200496DOI Listing
April 2012

Expression of fetal hemoglobin in adult humans exposed to high altitude hypoxia.

Blood Cells Mol Dis 2012 Mar 18;48(3):147-53. Epub 2012 Jan 18.

Department of Agricultural and Environment Science, University of Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2011.12.004DOI Listing
March 2012

Histone post-translational modifications associated to BAALC expression in leukemic cells.

Biochem Biophys Res Commun 2012 Jan 14;417(2):721-5. Epub 2011 Dec 14.

Istituto di Genetica Medica, Azienda Ospedaliero-Universitaria S. Maria della Misericordia Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2011.12.013DOI Listing
January 2012

Using the recognition code to swap homeodomain target specificity in cell culture.

Mol Biol Rep 2011 Nov 3;38(8):5349-54. Epub 2011 Mar 3.

Dipartimento di Scienze e Tecnologie Biomediche, Università di Udine, Piazzale Kolbe 1-33100 Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11033-011-0686-5DOI Listing
November 2011

Histone deacetylase inhibitors induce thymidine phosphorylase expression in cultured breast cancer cell lines.

Oncol Rep 2011 Aug 20;26(2):309-14. Epub 2011 May 20.

Dipartimento di Scienze e Tecnologie Biomediche, Università di Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2011.1310DOI Listing
August 2011

Levels of histone acetylation in thyroid tumors.

Biochem Biophys Res Commun 2011 Aug 3;411(4):679-83. Epub 2011 Jul 3.

Dipartimento di Scienze Mediche e Biologiche, Università di Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2011.06.182DOI Listing
August 2011

Epigenetics of thyroid cancer and novel therapeutic targets.

J Mol Endocrinol 2011 Jun 28;46(3):R73-81. Epub 2011 Apr 28.

Dipartimento di Scienze Farmacobiologiche, Università di Catanzaro, 88100 Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/JME-10-0150DOI Listing
June 2011

Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse.

Cancer 2011 May 29;117(10):2156-62. Epub 2010 Nov 29.

Division of Hematology and Bone Marrow Transplantation, Department of Medical and Morphological Researches, AOU Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25753DOI Listing
May 2011

In thyroid cancer cell lines expression of periostin gene is controlled by p73 and is not related to epigenetic marks of active transcription.

Cell Oncol (Dordr) 2011 Apr 27;34(2):131-40. Epub 2011 Jan 27.

Dipartimento di Scienze e Tecnologie Biomediche, Università di Udine, Piazzale Kolbe, 1-33100, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13402-011-0009-9DOI Listing
April 2011

Nucleophosmin delocalization in thyroid tumour cells.

Endocr Pathol 2011 Mar;22(1):18-23

Dipartimento di Scienze e Tecnologie Biomediche, Università di Udine, Piazzale Kolbe 1, 33100 Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12022-011-9147-xDOI Listing
March 2011

Plasminogen activator inhibitor-1 gene polymorphisms in pre-eclampsia.

Semin Thromb Hemost 2011 Mar 2;37(2):97-105. Epub 2011 Mar 2.

Istituto di Genetica Medica, AOUSMM Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0030-1270334DOI Listing
March 2011

Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells.

Oncol Rep 2011 Feb 7;25(2):393-7. Epub 2010 Dec 7.

Dipartimento di Scienze e Tecnologie Biomediche, Università di Udine, and Azienda Ospedaliero-Universitaria S. Maria della Misericordia, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2010.1075DOI Listing
February 2011

Quick MLPA test for quantification of SMN1 and SMN2 copy numbers.

Mol Cell Probes 2010 Oct 24;24(5):310-4. Epub 2010 Jul 24.

Dipartimento di Scienze e Tecnologie Biomediche, Università di Udine, P.le M. Kolbe 1, 33100 Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mcp.2010.07.001DOI Listing
October 2010

Two novel NPM1 mutations in a therapy-responder AML patient.

Hematol Oncol 2010 Sep;28(3):151-5

Dipartimento di Scienze e Tecnologie Biomediche, Facoltà di Medicina, Università di Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.906DOI Listing
September 2010

Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients.

Leuk Res 2010 Jul 31;34(7):942-5. Epub 2010 Jan 31.

Clinica Ematologica e Centro Trapianti e Terapie Cellulari C. Melzi, Azienda Ospedaliero-Universitaria di Udine, Dipartimento di Ricerche Mediche e Morfologiche, Università di Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S014521261000009
Publisher Site
http://dx.doi.org/10.1016/j.leukres.2010.01.008DOI Listing
July 2010

Nucleophosmin is overexpressed in thyroid tumors.

Biochem Biophys Res Commun 2010 Jul 31;397(3):499-504. Epub 2010 May 31.

Dipartimento di Scienze e Tecnologie Biomediche, Università di Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2010.05.142DOI Listing
July 2010

Conservation across species identifies several transcriptional enhancers in the HEX genomic region.

Mol Cell Biochem 2009 Dec 25;332(1-2):67-75. Epub 2009 Jun 25.

Azienda Ospedaliero-Universitaria S. Maria della Misericordia Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11010-009-0175-5DOI Listing
December 2009

Myelin protein zero Val102fs mutation manifesting with isolated spinal root hypertrophy.

Neuromuscul Disord 2009 Dec 10;19(12):849-52. Epub 2009 Nov 10.

Department of Neurology San Martino's Hospital, Belluno, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nmd.2009.09.004DOI Listing
December 2009

Thyroid tumors: novel insights from proteomic studies.

Expert Rev Proteomics 2009 Aug;6(4):363-76

Dipartimento di Scienze e Tecnologie Biomediche, Piazzale Kolbe 1, 33100 Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/epr.09.51DOI Listing
August 2009

Down-regulation of SM22/transgelin gene expression during H9c2 cells differentiation.

Mol Cell Biochem 2009 Jul 18;327(1-2):145-52. Epub 2009 Feb 18.

Dipartimento di Scienze e Tecnologie Biomediche, Università di Udine, Piazzale Kolbe 1, 33100 Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11010-009-0052-2DOI Listing
July 2009

DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells.

Int J Cancer 2009 Jun;124(11):2539-48

Department of Internal Medicine, Endocrinology Unit, University of Catania, Catania, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.24221DOI Listing
June 2009

A simple multiplex real-time PCR methodology for the SMN1 gene copy number quantification.

Genet Test Mol Biomarkers 2009 Feb;13(1):37-42

Dipartimento di Scienze e Tecnologie Biomediche, Università degli Studi, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/gtmb.2008.0084DOI Listing
February 2009

High periostin expression correlates with aggressiveness in papillary thyroid carcinomas.

J Endocrinol 2008 May;197(2):401-8

Dipartimento di Scienze e Tecnologie Biomediche, Università di Udine, Piazzale Kolbe 1, 33100 Udine, Italy.

View Article

Download full-text PDF

Source
https://joe.bioscientifica.com/view/journals/joe/197/2/401.x
Publisher Site
http://dx.doi.org/10.1677/JOE-07-0618DOI Listing
May 2008